🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tiantian Zheng

Zhejiang Chinese Medical University

ORCID: 0000-0002-9080-7937

Also affiliated with Zhengzhou University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer”.

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer

EBioMedicine(2020)10.1016/j.ebiom.2020.102728

N/A

0DataRank · unranked

136 citations

Winston Tan, Tiantian Zheng, Amy Wang, Carlos Montesinos, Calven Wong +10 more

Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer

Scientific Reports(2022)10.1038/s41598-022-08520-6

N/A

0DataRank · unranked

10 citations

Tiantian Zheng, Amy Wang, Joanna Roacho, Seng Thao, Pan Du +5 more

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype

EBioMedicine(2023)10.1016/j.ebiom.2023.104738

N/A

0DataRank · unranked

42 citations

Chao Dai, Edmond M. Kwan, Tiantian Zheng, Pan Du, Nicole Ng +12 more